Loading...

DENALI CAPITAL ACQUISITION CORP Company Mergers 8-K Filing

DNL

DENALI CAPITAL ACQUISITION CORP

()

2024 8-K

Summary

Summary

Merger Announcement

Merger Agreement Approved

Investment Agreement

Merger of Equals

Asset Acquisitions

Shareholder Meeting

Delisting Notice

Business Combination Extension

Business Extension

Business Combination Extension

Deadline Extension

Deadline Extension

Deadline Extension

Nasdaq Compliance Notice

Deadline Extension

Merger Agreement

Convertible Promissory Note...

Dismissal and Appointment o...

Convertible Promissory Note...

Business Combination Announ...

Termination of Merger Agree...

Shareholder Meeting

Postponement of Shareholder...

Amended and Restated Subscr...

Convertible Promissory Note...

Investor Presentation

Merger Agreement and Conver...

Merger Agreement

External Links:

Denali Capital Acquisition Corp. has entered into a merger agreement with Semnur Pharmaceuticals, valuing Semnur at $2.5 billion, with the merger expected to close in the first quarter of 2025.

AI Assistant

DENALI CAPITAL ACQUISITION CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.